Skip to main content
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ARTL ISIN · US04301G7060 US Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2019-06-04 Regulatory Filings
Country US United States of America
Listing US ARTL

About ARTELO BIOSCIENCES, INC.

https://artelobio.com/

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics. The company's scientific approach is centered on modifying lipid-signaling pathways, particularly by modulating the endocannabinoid system. Its primary therapeutic focus is on developing improved treatments for patients with cancer and other serious diseases. Artelo is advancing a diverse portfolio of drug candidates through its development pipeline to address unmet medical needs.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2019
Regulatory Filings
2019-06-04 English
FORM S-1 AMENDMENT NO. 2
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Amendment No. 2 registration statement filed with the SEC, dated May 31, 2019. It is a preliminary prospectus related to a securities offering, including common stock and warrants. The text includes detailed information about the offering, company overview, risk factors, management discussion, and other disclosures typical of a registration statement for an initial public offering or secondary offering. This type of filing is related to capital raising activities and financing, not an annual report, earnings release, or other categories. Therefore, the document fits the Capital/Financing Update (CAP) category.
2019-05-31 English
FORM S-1 AMENDMENT NO. 1
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Amendment No. 1 filed with the SEC, which is a registration statement under the Securities Act of 1933. It relates to the registration of securities for a public offering, including common stock and warrants. The document includes detailed information about the offering, the company, risk factors, management discussion, and financial statements. This type of filing is a capital raising document, specifically a registration statement for an initial or follow-on public offering. It is not an annual or quarterly report, audit report, earnings release, or any other type of report listed. The closest matching category is Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. Therefore, the document should be classified as CAP with high confidence.
2019-05-29 English
FORM 8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes details about entering into a material definitive agreement, unregistered sales of equity securities, and other events such as patent application updates. It does not contain comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). It is not a transcript, proxy, or governance document. The Form 8-K is a regulatory filing used to disclose material events promptly. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is over 5,000 characters and contains substantive event disclosures, confirming it is not merely an announcement of a report publication (RPA).
2019-04-30 English
FORM 10-Q
Interim / Quarterly Report Q2 2019
2019-04-15 English
FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used by companies to register securities for public offering under the Securities Act of 1933. It includes detailed information about the company, the securities being offered, risk factors, use of proceeds, management discussion, and financial data. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other type of report but specifically a registration statement for an initial or follow-on public offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full registration statement, not just an announcement.
2019-04-01 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.